Five steps. One workflow. Every step cited.
Demed follows the same path your team already runs — admission through de-escalation — and makes each decision point explicit, confident, and traceable to a source guideline.
A patient is admitted. Demed sees what you see.
MRN, age, sex, ward, allergies, and the presenting picture — the same intake data your team already records, structured so the rest of the workflow can reason over it.
One recommendation. Not a list to sift through.
Demed proposes a single primary empiric agent — drug, dose, route, frequency, duration — with a confidence breakdown across guideline fit, local resistance data, and patient-specific fit. You accept, modify with a documented reason, or reject. Every action is audited.
Renal and hepatic adjustment, calculated — not guessed.
Dose adjustments run through a deterministic rules engine (Cockcroft-Gault renal dosing, hepatic impairment logic) that never touches the language model. If the math can be done in code, it is done in code.
When cultures return, Demed narrows automatically.
As soon as culture and susceptibility results land, Demed re-ranks toward the narrowest effective agent — Access before Watch before Reserve — and shows exactly what it narrowed from and why.
Reminders fire the moment a case is ready to act on.
De-escalation and escalation candidates are flagged the moment new data makes them relevant — not on a fixed schedule, and not left for someone to notice on rounds.
Ask Demed sits alongside every step.
Outside the structured workflow, any clinical question can go straight to the guideline corpus — answered with the same citations you'd see in a recommendation, not a free-floating model opinion.
According to the IDSA 2025 complicated UTI guideline, empiric therapy depends on a four-step process: (1) assess illness severity, (2) evaluate risk factors for resistant organisms, (3) assess patient-specific factors, (4) consider the local antibiogram. Nitrofurantoin and oral fosfomycin are explicitly excluded — they don't achieve adequate levels in renal parenchyma or blood.
See it on your own cases.
The pilot program runs on real admissions, with Demed's clinical lead validating every recommendation alongside your team.
Request a pilot